Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Tina Bernthaler"'
Autor:
Dieter Fink, Ulrike Pfeiffenberger, Tina Bernthaler, Sophie Schober, Kerstin E Thonhauser, Thomas Rülicke
Publikováno v:
PLoS ONE, Vol 14, Iss 11, p e0224576 (2019)
Intra-bone marrow transplantation (IBMT) has been adapted for mouse models to improve the seeding efficiency of transplanted hematopoietic stem and progenitor cells. Commonly used injection volumes for IBMT into the tibia differ between 10 and 40 μL
Externí odkaz:
https://doaj.org/article/4db0e543c0284246a13e79401a3444e6
Autor:
Michael Willmann, Barbara Peter, Katharina Slavnitsch, Daniela Berger, Nadine Witzeneder, Gabriele Stefanzl, Gregor Eisenwort, Daniel Ivanov, Irina Sadovnik, Emir Hadzijusufovic, Georg Greiner, Tina Bernthaler, Gregor Hoermann, Maik Dahlhoff, Thomas Rülicke, Peter Valent
Publikováno v:
Leukemia. 37:1162-1165
Autor:
Nicole Amberg, Lill Andersen, Amarbayasgalan Davaatseren, Liqun Luo, Johanna Sonntag, Simon Hippenmeyer, Andi H. Hansen, Thomas Rülicke, Anna-Magdalena Heger, Lindsay A. Schwarz, Carmen Streicher, Tina Bernthaler, Randy L. Johnson, Ximena Contreras
Publikováno v:
Cell Reports
Cell Rep
Cell Rep
SUMMARY: Mosaic analysis with double markers (MADM) offers one approach to visualize and concomitantly manipulate genetically defined cells in mice with single-cell resolution. MADM applications include the analysis of lineage, single-cell morphology
Autor:
Amarbayasgalan Davaatseren, Simon Hippenmeyer, Randy L. Johnson, Anna Heger, Lill Andersen, Tina Bernthaler, Ximena Contreras, Johanna Sonntag, Thomas Rülicke, Liqun Luo, Nicole Amberg, Andi H. Hansen, Lindsay A. Schwarz
Publikováno v:
bioRxiv
The Preprint Server for Biology
The Preprint Server for Biology
SUMMARYMosaic Analysis with Double Markers (MADM) offers a unique approach to visualize and concomitantly manipulate genetically-defined cells in mice with single-cell resolution. MADM applications include the analysis of lineage; single-cell morphol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8829eb50f8d373a4218d637d8813014
https://doi.org/10.1101/2020.06.05.136192
https://doi.org/10.1101/2020.06.05.136192
Autor:
Michael Willmann, Gregor Eisenwort, Peter Valent, Thomas Rülicke, Gabriele Stefanzl, Gregor Hoermann, Tina Bernthaler, Emir Hadzijusufovic, Harald Herrmann, Martin Entner, Irina Sadovnik, Daniela Berger
Publikováno v:
Exp Hematol
Chronic myeloid leukemia (CML) is a stem cell (SC) neoplasm characterized by the BCR/ABL1 oncogene. Although the disease can be kept under control using BCR/ABL1 tyrosine kinase inhibitors (TKIs) in most cases, some patients relapse or have resistant